Hippocampal Proliferation Is Increased in Presymptomatic Parkinson’s Disease and due to Microglia
Open accessThe DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Besides dopamine-deficiency related motor symptoms, nonmotor symptoms, including cognitive changes occur in Parkinson's disease (PD) patients, that may relate to accumulation of α-synuclein in the hippocampus (HC). This brain region also contains stem cells that can proliferate. This is a well-regulated process that can, for example, be altered by neurodegenerative conditions. In contrast to proliferation in the substantia nigra and subventricular zone, little is known about the HC in PD. In addition, glial cells contribute to neurodegenerative processes and may proliferate in response to PD pathology. In the present study, we questioned whether microglial cells proliferate in the HC of established PD patients versus control subjects or incidental Lewy body disease (iLBD) cases as a prodromal state of PD. To this end, proliferation was assessed using the immunocytochemical marker minichromosome maintenance protein 2 (MCM2). Colocalization with Iba1 was performed to determine microglial proliferation. MCM2-positive cells were present in the HC of controls and were significantly increased in the presymptomatic iLBD cases, but not in established PD patients. Microglia represented the majority of the proliferating cells in the HC. This suggests an early microglial response to developing PD pathology in the HC and further indicates that neuroinflammatory processes play an important role in the development of PD pathology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased microglial proliferation has been described in the brains of AD patients (135), and in the prodromal stage of Parkinson disease (136), suggesting that microglial proliferation is an early event in the course of neurodegenerative diseases.”
From Microglia in Alzheimer's disease (2017) · cites this paper as [136]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Neurogenesis in the adult human hippocampus
Eriksson, P. S., Perfilieva, E., Björk-Eriksson, T., Alborn, A.-M., Nordborg, C., Peterson, D. A., & Gage, F. H. (1998) · Nature Medicine · doi:10.1038/3305 · Cited by 6,369 · cited 1×
“In control subjects, the low number of MCM2-positive proliferating cells observed in the HC is consistent with the low rates of hippocampal proliferation and neurogenesis found before in the aged rodent, primate, and human HC and in comparable PD brain tissue [30, 41, 48–51].”
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,105
A Functional Role for Adult Hippocampal Neurogenesis in Spatial Pattern Separation
Clelland, C. D., Choi, M., Romberg, C., Clemenson, G. D., Fragniere, A., Tyers, P., Jessberger, S., Saksida, L. M., Barker, R. A., Gage, F. H., et al. (2009) · Science · doi:10.1126/science.1173215 · Cited by 1,642 · cited 1×
“Thus far, little attention has been paid to cellular proliferative changes in the human HC, a brain region relevant for nonmotor symptoms in PD, like cognitive and depressive changes.”
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Dopamine depletion impairs precursor cell proliferation in Parkinson disease
Höglinger, G. U., Rizk, P., Muriel, M. P., Duyckaerts, C., Oertel, W. H., Caille, I., & Hirsch, E. C. (2004) · Nature Neuroscience · doi:10.1038/nn1265 · Cited by 944 · cited 3×
“Regarding PD, stem cells and related cellular plasticity markers are also altered in relevant animal models [24–26], but only few studies exist on proliferative changes in human PD brain [26], most of which have focused on the SN [27, 28] and subventricular zone (SVZ) [29, 30].”
Neurogenesis in the striatum of the adult human brain
Ernst, A., Alkass, K., Bernard, S., Salehpour, M., Perl, S., Tisdale, J., Possnert, G., Druid, H., & Frisén, J. (2014) · Cell · doi:10.1016/j.cell.2014.01.044 · Cited by 937
Kim, C., Ho, D.-H., Suk, J.-E., You, S., Michael, S., Kang, J., Joong Lee, S., Masliah, E., Hwang, D., Lee, H.-J., et al. (2013) · Nature Communications · doi:10.1038/ncomms2534 · Cited by 856
Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression
Gao, H.-M., & Hong, J.-S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.05.002 · Cited by 821 · cited 1×
“In most PD cases, neuronal populations in the HC show accumulation of α-synuclein [56, 57] which may activate the brain’s immune system through microglia activation [58].”
Exercise-enhanced neuroplasticity targeting motor and cognitive circuitry in Parkinson's disease
Petzinger, G. M., Fisher, B. E., McEwen, S., Beeler, J. A., Walsh, J. P., & Jakowec, M. W. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70123-6 · Cited by 798 · cited 1×
“Stimulation of cellular plasticity on the other hand, for example through exercise, antidepressant treatment or high frequency stimulation, reverses impairments in neurogenesis in PD models [20] and may even benefit PD patients [21, 22].”
Continuation of neurogenesis in the hippocampus of the adult macaque monkey
Kornack, D. R., & Rakic, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5768 · Cited by 778 · cited 1×
“In control subjects, the low number of MCM2-positive proliferating cells observed in the HC is consistent with the low rates of hippocampal proliferation and neurogenesis found before in the aged rodent, primate, and human HC and in comparable PD brain tissue [30, 41, 48–51].”
Turnover of resident microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., & Gordon, S. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90500-2 · Cited by 709 · cited 1×
“In related prion disease models, proliferation of microglial cells is considered important in their turnover [64, 65] and to a larger extent to account for the expansion of the resident microglia population during, for example, prion disease development [66].”
Braak, H., Del Tredici, K., Bratzke, H., Hamm-Clement, J., Sandmann-Keil, D., & Rüb, U. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1301-4 · Cited by 708 · cited 1×
“According to the staging concept described by Braak, α-synuclein deposition spreads over the brain in an anatomically predictable manner [6].”
Glial reactions in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701
Neuroinflammation in Parkinson's disease
Hirsch, E. C., Vyas, S., & Hunot, S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70065-7 · Cited by 657
Taupin, P. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.08.002 · Cited by 645
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-09.2009 · Cited by 591
Evidence for neurogenesis in the adult mammalian substantia nigra
Zhao, M., Momma, S., Delfani, K., Carlén, M., Cassidy, R. M., Johansson, C. B., Brismar, H., Shupliakov, O., Frisén, J., & Janson, A. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131955100 · Cited by 590 · cited 1×
“In the human SN and SVZ, discrepant results have been obtained between different studies, and this topic remains subject of debate [26, 29, 31–34].”
Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies
Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., & de Bernard, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055375 · Cited by 585
The epidemiology of dementia associated with Parkinson disease
Aarsland, D., & Kurz, M. W. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.034 · Cited by 578
Role of the Toll-Like Receptor 4 in Neuroinflammation in Alzheimer’s Disease
Walter, S., Letiembre, M., Liu, Y., Heine, H., Penke, B., Hao, W., Bode, B., Manietta, N., Walter, J., Schulz-Schüffer, W., et al. (2007) · Cellular Physiology and Biochemistry · doi:10.1159/000110455 · Cited by 543 · cited 1×
“Similar to amyloid-beta, such secreted proteins can be “sensed” by microglia through toll-like receptors that could lead to the activation of inflammatory response genes and their proliferation [61, 69, 71, 77–79].”
Maslov, A. Y., Barone, T. A., Plunkett, R. J., & Pruitt, S. C. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4608-03.2004 · Cited by 522 · cited 2×
“MCM2 expression starts in early G1 and is maintained throughout the cell cycle, also in cells that proliferate without actually synthesizing DNA, and is thus present in higher numbers than, for example, the short-lived proliferation marker Ki67 [38, 45, 46].”
Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?
Herrup, K., & Yang, Y. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2124 · Cited by 507 · cited 1×
“Although earlier studies suggested that proliferation outside neurogenic regions may reflect “endangered” neurons that attempt to reenter the cell cycle [55], there are no indications that proliferation in the CA subregions will actually give rise to new neurons.”
Bezard, E., Dovero, S., Prunier, C., Ravenscroft, P., Chalon, S., Guilloteau, D., Crossman, A. R., Bioulac, B., Brotchie, J. M., & Gross, C. E. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-17-06853.2001 · Cited by 483
Synuclein activates microglia in a model of Parkinson's disease
Su, X., Maguire-Zeiss, K. A., Giuliano, R., Prifti, L., Venkatesh, K., & Federoff, H. J. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.006 · Cited by 474 · cited 1×
“While in vitro studies had already demonstrated that the aggregated form of α-synuclein can trigger microglial activation [10, 68], the HC of iLBD cases is largely devoid of α-synuclein depositions, and a role for soluble forms or αsynuclein oligomers can thus not be excluded.”
Stiasny-Kolster, K. (2004) · Brain · doi:10.1093/brain/awh322 · Cited by 430
Immunohistological markers for staging neurogenesis in adult hippocampus
von Bohlen und Halbach, O. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0432-4 · Cited by 411 · cited 3×
“…p.j.lucassen@uva.nl Received 13 May 2014; Accepted 1 July 2014; Published 14 August 2014 Academic Editor: Carlos Fitzsimons Copyright © 2014 Karlijn J. Doorn et al.This is an open access article distributed under theCreative CommonsAttribution License, which permits unrestricted use, distribution,…”
BackgroundInfluentialRegulation of Microglial Proliferation during Chronic Neurodegeneration
Gómez-Nicola, D., Fransen, N. L., Suzzi, S., & Perry, V. H. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4440-12.2013 · Cited by 407 · cited 1×
“In related prion disease models, proliferation of microglial cells is considered important in their turnover [64, 65] and to a larger extent to account for the expansion of the resident microglia population during, for example, prion disease development [66].”
Neurodegenerative disease and adult neurogenesis
Winner, B., Kohl, Z., & Gage, F. H. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07613.x · Cited by 405
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion‐Like Disorder?
Olanow, C. W., & Brundin, P. (2013) · Movement Disorders · doi:10.1002/mds.25373 · Cited by 390
Bruno, S., & Darzynkiewicz, Z. (1992) · Cell Proliferation · doi:10.1111/j.1365-2184.1992.tb01435.x · Cited by 375 · cited 1×
“MCM2 expression starts in early G1 and is maintained throughout the cell cycle, also in cells that proliferate without actually synthesizing DNA, and is thus present in higher numbers than, for example, the short-lived proliferation marker Ki67 [38, 45, 46].”
Epidemiology of Parkinson’s disease
Alves, G., Forsaa, E. B., Pedersen, K. F., Dreetz Gjerstad, M., & Larsen, J. P. (2008) · Journal of Neurology · doi:10.1007/s00415-008-5004-3 · Cited by 363
Clearance and deposition of extracellular α-synuclein aggregates in microglia
Lee, H.-J., Suk, J.-E., Bae, E.-J., & Lee, S.-J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.045 · Cited by 343 · cited 1×
“Several forms of α-synuclein have been found to induce microglial activation [10, 75, 76].”
Progressive degeneration of human neural stem cells caused by pathogenic LRRK2
Liu, G.-H., Qu, J., Suzuki, K., Nivet, E., Li, M., Montserrat, N., Yi, F., Xu, X., Ruiz, S., Zhang, W., et al. (2012) · Nature · doi:10.1038/nature11557 · Cited by 339
The Epidemiology of Dementia Associated with Parkinson's Disease
Aarsland, D., & Kurz, M. W. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00369.x · Cited by 338 · cited 1×
“These symptoms strongly affect quality of life of PD patients as they include autonomic dysfunction, sleep problems, cognitive and neuropsychiatric changes [2–5], all changes unrelated to degeneration of the substantia nigra (SN).”
Boekhoorn, K., Joels, M., & Lucassen, P. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.017 · Cited by 325 · cited 1×
“Various tests to validate and confirm specificity of MCM2 and related markers have been performed by us and others before [38, 46, 47], for example, on samples of young rat brain and human colon, that were processed and embedded in the exact same way as the human brain tissue used in the current study [39, 41].”
Self-citationvon Bohlen und Halbach, O. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1196-4 · Cited by 313
Impaired human hippocampal neurogenesis after treatment for central nervous system malignancies
Monje, M. L., Vogel, H., Masek, M., Ligon, K. L., Fisher, P. G., & Palmer, T. D. (2007) · Annals of Neurology · doi:10.1002/ana.21214 · Cited by 311
Cortical Lewy body pathology in the diagnosis of dementia
Harding, A. J., & Halliday, G. M. (2001) · Acta Neuropathologica · doi:10.1007/s004010100390 · Cited by 297 · cited 1×
“In most PD cases, neuronal populations in the HC show accumulation of α-synuclein [56, 57] which may activate the brain’s immune system through microglia activation [58].”
Baker, S. A., Baker, K. A., & Hagg, T. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03486.x · Cited by 258 · cited 1×
“Our current hippocampal data are in contrast with a previous study on proliferation in the SVZ in PD and PD models [29], indicating that cell proliferation in the SVZ, and possibly also in the DG, may be under dopaminergic control [16, 29, 81, 82].”
Doorn, K. J., Moors, T., Drukarch, B., van de Berg, W. D., Lucassen, P. J., & van Dam, A.-M. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0090-1 · Cited by 254
Self-citationNitrated alpha‐synuclein‐activated microglial profiling for Parkinson’s disease
Reynolds, A. D., Glanzer, J. G., Kadiu, I., Ricardo‐Dukelow, M., Chaudhuri, A., Ciborowski, P., Cerny, R., Gelman, B., Thomas, M. P., Mosley, R. L., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05087.x · Cited by 244 · cited 1×
“Several forms of 𝛼 -synuclein have been found to induce microglial activation [10, 75, 76].”
Sommer, U., Hummel, T., Cormann, K., Mueller, A., Frasnelli, J., Kropp, J., & Reichmann, H. (2004) · Movement Disorders · doi:10.1002/mds.20141 · Cited by 244
Rao, M. S., Hattiangady, B., & Shetty, A. K. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00243.x · Cited by 241
Microglia in the CNS: Immigrants from another world
Prinz, M., & Mildner, A. (2011) · Glia · doi:10.1002/glia.21104 · Cited by 235 · cited 1×
“In related prion disease models, proliferation of microglial cells is considered important in their turnover [64, 65] and to a larger extent to account for the expansion of the resident microglia population during, for example, prion disease development [66].”
Lucassen, P. J., Stumpel, M. W., Wang, Q., & Aronica, E. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.01.012 · Cited by 212 · cited 2×
“Various tests to validate and confirm specificity of MCM2 and related markers have been performed by us and others before [38, 46, 47], for example, on samples of young rat brain and human colon, that were processed and embedded in the exact same way as the human brain tissue used in the current study [39, 41].”
Self-citationTreatment of Parkinson's disease: levodopa as the first choice
Katzenschlager, R., & Lees, A. J. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1204-4 · Cited by 209
Cognitive decline correlates with neuropathological stage in Parkinson's disease
Braak, H., Rüb, U., & Del Tredici, K. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.05.011 · Cited by 209 · cited 1×
“These symptoms strongly affect quality of life of PD patients as they include autonomic dysfunction, sleep problems, cognitive and neuropsychiatric changes [2–5], all changes unrelated to degeneration of the substantia nigra (SN).”
The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease
Gaenslen, A., Swid, I., Liepelt‐Scarfone, I., Godau, J., & Berg, D. (2011) · Movement Disorders · doi:10.1002/mds.23499 · Cited by 198 · cited 1×
“These symptoms strongly affect quality of life of PD patients as they include autonomic dysfunction, sleep problems, cognitive and neuropsychiatric changes [2–5], all changes unrelated to degeneration of the substantia nigra (SN).”
Dopamine and adult neurogenesis
Borta, A., & Höglinger, G. U. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04241.x · Cited by 192 · cited 1×
“Regarding PD, stem cells and related cellular plasticity markers are also altered in relevant animal models [24–26], but only few studies exist on proliferative changes in human PD brain [26], most of which have focused on the SN [27, 28] and subventricular zone (SVZ) [29, 30].”
Prion-like spread of protein aggregates in neurodegeneration
Polymenidou, M., & Cleveland, D. W. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120741 · Cited by 184 · cited 1×
“The release of α-synuclein and the subsequent uptake by neighboring neurons or glia suggest possibilities for cell-to-cell transfer and propagation that was recently proposed as conceptual model for proteinopathies [71, 72] and is consistent with the spatiotemporal progression of PD neuropathology over the brain [73].”
Adult neurogenesis in Parkinson’s disease
Marxreiter, F., Regensburger, M., & Winkler, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1062-x · Cited by 182 · cited 2×
“Regarding PD, stem cells and related cellular plasticity markers are also altered in relevant animal models [24–26], but only few studies exist on proliferative changes in human PD brain [26], most of which have focused on the SN [27, 28] and subventricular zone (SVZ) [29, 30].”
Spatial and Temporal Patterns of Cell Division during Early Xenopus Embryogenesis
Saka, Y., & Smith, J. C. (2001) · Developmental Biology · doi:10.1006/dbio.2000.0101 · Cited by 172 · cited 1×
“Various tests to validate and confirm specificity of MCM2 and related markers have been performed by us and others before [38, 46, 47], for example, on samples of young rat brain and human colon, that were processed and embedded in the exact same way as the human brain tissue used in the current study [39, 41].”
Brainstem pathology and non-motor symptoms in PD
Grinberg, L. T., Rueb, U., Alho, A. T. D. L., & Heinsen, H. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.08.021 · Cited by 162 · cited 1×
“These symptoms strongly affect quality of life of PD patients as they include autonomic dysfunction, sleep problems, cognitive and neuropsychiatric changes [2–5], all changes unrelated to degeneration of the substantia nigra (SN).”
Fahrner, A., Kann, G., Flubacher, A., Heinrich, C., Freiman, T. M., Zentner, J., Frotscher, M., & Haas, C. A. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.023 · Cited by 160 · cited 1×
“Of these, the minichromosome maintenance protein 2 (MCM2) is involved in the control of DNA replication and commonly used in cancer research as a reliable marker for detecting dividing and slowly cycling putative stem cells in situ [38, 43, 44].”
Striatal deafferentation increases dopaminergic neurogenesis in the adult olfactory bulb
Winner, B., Geyer, M., Couillard-Despres, S., Aigner, R., Bogdahn, U., Aigner, L., Kuhn, G., & Winkler, J. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.08.028 · Cited by 159 · cited 2×
“Our current hippocampal data are in contrast with a previous study on proliferation in the SVZ in PD and PD models [29], indicating that cell proliferation in the SVZ, and possibly also in the DG, may be under dopaminergic control [16, 29, 81, 82].”
Human Wild-Type α-Synuclein Impairs Neurogenesis
Winner, B., Lie, D. C., Rockenstein, E., Aigner, R., Aigner, L., Masliah, E., Kuhn, H. G., & Winkler, J. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.11.1155 · Cited by 150
Imamura, K., Hishikawa, N., Ono, K., Suzuki, H., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0919-y · Cited by 138 · cited 2×
“While different microglial Neural Plasticity phenotypes are present in the SN, HC, and OB in PD, their functional role and hence the implications of microglia proliferation for PD etiology remain elusive [37, 59–61].”
Differential cell proliferation in the cortex of the appsweps1de9 alzheimer's disease mouse model
Kamphuis, W., Orre, M., Kooijman, L., Dahmen, M., & Hol, E. M. (2012) · Glia · doi:10.1002/glia.22295 · Cited by 137
Crews, L., Mizuno, H., Desplats, P., Rockenstein, E., Adame, A., Patrick, C., Winner, B., Winkler, J., & Masliah, E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0066-08.2008 · Cited by 130
Hippocampal abnormalities and memory deficits in Parkinson disease: A multimodal imaging study
Carlesimo, G. A., Piras, F., Assogna, F., Pontieri, F. E., Caltagirone, C., & Spalletta, G. (2012) · Neurology · doi:10.1212/wnl.0b013e318259e1c5 · Cited by 126 · cited 1×
“Accumulation of α-synuclein has been reported in the hippocampus (HC), which may contribute to the cognitive and depressive changes that represent prominent nonmotor symptoms in PD [11, 12] (Figure 1).”
Possibility for neurogenesis in substantia nigra of parkinsonian brain
Yoshimi, K., Ren, Y., Seki, T., Yamada, M., Ooizumi, H., Onodera, M., Saito, Y., Murayama, S., Okano, H., Mizuno, Y., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20506 · Cited by 123
Curtis, M. A., Low, V. F., & Faull, R. L. M. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22028 · Cited by 121
Role of α-Synuclein in Adult Neurogenesis and Neuronal Maturation in the Dentate Gyrus
Winner, B., Regensburger, M., Schreglmann, S., Boyer, L., Prots, I., Rockenstein, E., Mante, M., Zhao, C., Winkler, J., Masliah, E., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.2723-12.2012 · Cited by 119
Mature astrocytes in the adult human neocortex express the early neuronal marker doublecortin
Verwer, R. W. H., Sluiter, A. A., Balesar, R. A., Baayen, J. C., Noske, D. P., Dirven, C. M. F., Wouda, J., van Dam, A. M., Lucassen, P. J., & Swaab, D. F. (2007) · Brain · doi:10.1093/brain/awm264 · Cited by 118 · cited 1×
“The methodological limitations that exist for visualization of neuronal proliferation in human postmortem brain [83–88] do not seem to hold explicitly for microglia proliferation.”
Self-citationThe proliferative capacity of the subventricular zone is maintained in the parkinsonian brain
van den Berge, S. A., van Strien, M. E., Korecka, J. A., Dijkstra, A. A., Sluijs, J. A., Kooijman, L., Eggers, R., De Filippis, L., Vescovi, A. L., Verhaagen, J., et al. (2011) · Brain · doi:10.1093/brain/awr256 · Cited by 118
-Syn Suppression Reverses Synaptic and Memory Defects in a Mouse Model of Dementia with Lewy Bodies
Lim, Y., Kehm, V. M., Lee, E. B., Soper, J. H., Li, C., Trojanowski, J. Q., & Lee, V. M. Y. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0618-11.2011 · Cited by 114
Impairment of in vivo calcium signaling in amyloid plaque-associated microglia
Brawek, B., Schwendele, B., Riester, K., Kohsaka, S., Lerdkrai, C., Liang, Y., & Garaschuk, O. (2014) · Acta Neuropathologica · doi:10.1007/s00401-013-1242-2 · Cited by 112 · cited 1×
“Another possibility is that proliferative changes reflect altered calcium signaling that was, for example, found to be dysregulated in microglia in close vicinity to amyloid plaques in AD brain [80].”
Dopaminergic modulation of neurogenesis in the subventricular zone of the adult brain
O’Keeffe, G. C., Barker, R. A., & Caldwell, M. A. (2009) · Cell Cycle · doi:10.4161/cc.8.18.9512 · Cited by 102
Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model
Kohl, Z., Winner, B., Ubhi, K., Rockenstein, E., Mante, M., Münch, M., Barlow, C., Carter, T., Masliah, E., & Winkler, J. (2012) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07933.x · Cited by 101 · cited 1×
“Stimulation of cellular plasticity on the other hand, for example through exercise, antidepressant treatment or high frequency stimulation, reverses impairments in neurogenesis in PD models [20] and may even benefit PD patients [21, 22].”
Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease
Doorn, K. J., Lucassen, P. J., Boddeke, H. W. G. M., Prins, M., Berendse, H. W., Drukarch, B., & van Dam, A. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.005 · Cited by 101 · cited 1×
“As activatedmicroglial cells are present in the HC in PD and implicated in PD pathogenesis [9, 37], we also questionedwhethermicroglial cells proliferate in these conditions.”
Self-citationIncreased Amoeboid Microglial Density in the Olfactory Bulb of Parkinson's and Alzheimer's Patients
Doorn, K. J., Goudriaan, A., Blits‐Huizinga, C., Bol, J. G. J. M., Rozemuller, A. J., Hoogland, P. V. J. M., Lucassen, P. J., Drukarch, B., van de Berg, W. D. J., & van Dam, A. (2014) · Brain Pathology · doi:10.1111/bpa.12088 · Cited by 99
Self-citationNeurogenesis and Alzheimers Disease: Biology and Pathophysiology in Mice and Men
Marlatt, M., & Lucassen, P. (2010) · Current Alzheimer Research · doi:10.2174/156720510790691362 · Cited by 88 · cited 1×
“In the human SN and SVZ, discrepant results have been obtained between different studies, and this topic remains subject of debate [26, 29, 31–34].”
Self-citationDesplats, P., Patel, P., Kosberg, K., Mante, M., Patrick, C., Rockenstein, E., Fujita, M., Hashimoto, M., & Masliah, E. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-49 · Cited by 86
Marlatt, M. W., Bauer, J., Aronica, E., van Haastert, E. S., Hoozemans, J. J. M., Joels, M., & Lucassen, P. J. (2014) · Neural Plasticity · doi:10.1155/2014/693851 · Cited by 83 · cited 1×
“As activated microglial cells are present in the HC in PD and implicated in PD pathogenesis [9, 37], we also questioned whether microglial cells proliferate in these conditions.”
Self-citationAdult Neurogenesis: Can Analysis of Cell Cycle Proteins Move Us "Beyond BrdU"?
Eisch, A. J., & Mandyam, C. D. (2007) · Current Pharmaceutical Biotechnology · doi:10.2174/138920107780906540 · Cited by 79 · cited 1×
“The methodological limitations that exist for visualization of neuronal proliferation in human postmortem brain [83–88] do not seem to hold explicitly for microglia proliferation.”
Desplats, P., Spencer, B., Crews, L., Pathel, P., Morvinski-Friedmann, D., Kosberg, K., Roberts, S., Patrick, C., Winner, B., Winkler, J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.354522 · Cited by 74
van de Berg, W. D. J., Hepp, D. H., Dijkstra, A. A., Rozemüller, A. J. M., Berendse, H. W., & Foncke, E. M. J. (2011) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70011-6 · Cited by 70 · cited 2×
“This coincides with the occurrence of nonmotor symptoms and can be observed already in early stages of PD, that is, in incidental Lewy body disease (iLBD) [7].”
Antiviral drug ganciclovir is a potent inhibitor of microglial proliferation and neuroinflammation
Ding, Z., Mathur, V., Ho, P. P., James, M. L., Lucin, K. M., Hoehne, A., Alabsi, H., Gambhir, S. S., Steinman, L., Luo, J., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20120696 · Cited by 68
Suzuki, K., Okada, K., Wakuda, T., Shinmura, C., Kameno, Y., Iwata, K., Takahashi, T., Suda, S., Matsuzaki, H., Iwata, Y., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009260 · Cited by 66 · cited 1×
“Also striatal deafferentiation, or the loss of dopaminergic neurons, affects both neurogenesis [16] and proliferation in the HC [17].”
Vedam-Mai, V., Gardner, B., Okun, M. S., Siebzehnrubl, F. A., Kam, M., Aponso, P., Steindler, D. A., Yachnis, A. T., Neal, D., Oliver, B. U., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088770 · Cited by 55
MCM2 and Ki-67 Expression in Human Lung Adenocarcinoma: Prognostic Implications
Hashimoto, K., Araki, K., Osaki, M., Nakamura, H., Tomita, K., Shimizu, E., & Ito, H. (2004) · Pathobiology · doi:10.1159/000078673 · Cited by 49 · cited 1×
“Of these, the minichromosome maintenance protein 2 (MCM2) is involved in the control of DNA replication and commonly used in cancer research as a reliable marker for detecting dividing and slowly cycling putative stem cells in situ [38, 43, 44].”
Origin of the dopaminergic innervation of adult neurogenic areas
Höglinger, G. U., Arias‐Carrión, O., Ipach, B., & Oertel, W. H. (2014) · Journal of Comparative Neurology · doi:10.1002/cne.23537 · Cited by 46 · cited 1×
“Our current hippocampal data are in contrast with a previous study on proliferation in the SVZ in PD and PD models [29], indicating that cell proliferation in the SVZ, and possibly also in the DG, may be under dopaminergic control [16, 29, 81, 82].”
Armstrong, R. A., Kotzbauer, P. T., Perlmutter, J. S., Campbell, M. C., Hurth, K. M., Schmidt, R. E., & Cairns, N. J. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1084-z · Cited by 42
Neurogenesis in Substantia Nigra of Parkinsonian Brains?
Arias-Carrión, Ó., Yamada, E. S., Freundlieb, N., Djufri, M., Maurer, L., Hermanns, G., Ipach, B., Chiu, W., Steiner, C., Oertel, W. H., et al. (2009) · Springer eBooks · doi:10.1007/978-3-211-92660-4_23 · Cited by 32
Harnessing neurogenesis for the possible treatment of Parkinson's disease
Lamm, O., Ganz, J., Melamed, E., & Offen, D. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23607 · Cited by 31 · cited 1×
“Stimulation of cellular plasticity on the other hand, for example through exercise, antidepressant treatment or high frequency stimulation, reverses impairments in neurogenesis in PD models [20] and may even benefit PD patients [21, 22].”
Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma
Reena, R. M. Z., Mastura, M., Siti-Aishah, M. A., Munirah, M. A., Norlia, A., Naqiyah, I., Rohaizak, M., & Sharifah, N. A. (2008) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2008.04.001 · Cited by 19 · cited 2×
“Sections were mounted on positively charged glass slides (Menzel-Glaser SuperFrost Plus, Braunschweig, Germany).”
Quantitative evaluation of the human subventricular zone
Höglinger, G. U., Barker, R., Hagg, T., Arias-Carrión, Ó., Caldwell, M. A., & Hirsch, É. C. (2012) · Brain · doi:10.1093/brain/aws087 · Cited by 11 · cited 1×
“While followed by an interesting debate [32, 33], this also suggested that proliferating progenitor cells are at least not reduced in PD.”
Reply: Quantitative evaluation of the human subventricular zone
van den Berge, S. A., van Strien, M. E., Korecka, J. A., Dijkstra, A. A., Sluijs, J. A., Kooijman, L., Eggers, R., Filippis, L. D., Vescovi, A. L., Verhaagen, J., et al. (2012) · Brain · doi:10.1093/brain/aws088 · Cited by 5
Research works printed but not linked: 5
- 2002, Journal of Neurology, 249, 1
- 2012, Parkinsonism & Related Disorders, 18, S28
- 2009, Journal of Neural Transmission. Supplementum, 279
- 2014, PloS ONE, 9
- 2012, Parkinsonism and Related Disorders, 18, S210
Cited by
Microglia in Alzheimer's disease
Sarlus, H., & Heneka, M. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90606 · Cited by 911
“Increased microglial proliferation has been described in the brains of AD patients (135), and in the prodromal stage of Parkinson disease (136), suggesting that microglial proliferation is an early event in the course of neurodegenerative diseases.”
BackgroundHuman adult neurogenesis across the ages: An immunohistochemical study
Dennis, C. V., Suh, L. S., Rodriguez, M. L., Kril, J. J., & Sutherland, G. T. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12337 · Cited by 265
Bassett, B., Subramaniyam, S., Fan, Y., Varney, S., Pan, H., Carneiro, A. M. D., & Chung, C. Y. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.11.009 · Cited by 217
Brain region-specific gene expression profiles in freshly isolated rat microglia
Doorn, K. J., Brevé, J. J. P., Drukarch, B., Boddeke, H. W., Huitinga, I., Lucassen, P. J., & van Dam, A.-M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00084 · Cited by 109
“Subsequently, cells were rinsed twice in PBS, pelleted at 1200 rpm for 5 min at 4 ◦ C and resus-pended in 300 μ l PBS before they were filtered over a 70 μ m size strainer to obtain a single cell suspension ready for FACS analysis and sorting.”
Self-citationMarlatt, M. W., Bauer, J., Aronica, E., van Haastert, E. S., Hoozemans, J. J. M., Joels, M., & Lucassen, P. J. (2014) · Neural Plasticity · doi:10.1155/2014/693851 · Cited by 83
Self-citation
Metadata
- Authors
- Doorn, K. J., Drukarch, B., van Dam, A.-M., & Lucassen, P. J.
- Affiliations
- Amsterdam Neuroscience (NL)
- Neuroscience Campus Amsterdam (NCA), Free University (VU) Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands
- University of Amsterdam (NL)
- Corresponding author
- Lucassen, Paul J.
- Venue
- Neural Plasticity
- Publisher
- Hindawi Limited
- Published
- 2014
- Volume
- 2014
- Pages
- 1-13
- ISSN
- 1687-5443 (ISSN-L)
- 2090-5904
- PMC
- PMC4147270
- OpenAlex
- W1966166173
- Cited by
- 24
- References
- 91
- Citations by year
- 2026: 1 · 2025: 1 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 3 · 2014: 2
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Neural Plasticity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- UvA-DARE (University of Amsterdam) (acceptedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Internationale Parkinson Fonds (IPF)
- Alzheimer Nederland and the Internationale Stichting Alzheimer Onderzoek (ISAO)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- Parkinson's disease, incidental Lewy body disease, hippocampus, microglial proliferation, neuroinflammation, MCM2, Iba1, alpha-synuclein, non-motor symptoms, prodromal Parkinson's disease
- MeSH terms
- Aged, Aged, 80 and over, Female, Hippocampus, Humans, Male, Parkinson Disease, Microglia, Cell Proliferation, alpha-Synuclein, Prodromal Symptoms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.